DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mitiglinide
Mitiglinide
Download Product Catalog
Specifications of Approved Drug Compound Library
Stems for Nonproprietary Drug Names
Sulfonylurea Stimulation of Insulin Secretion Peter Proks,1 Frank Reimann,2 Nick Green,1 Fiona Gribble,2 and Frances Ashcroft1
Pharmacokinetic and Pharmacodynamic Modeling of Oral
Jp Xvii the Japanese Pharmacopoeia
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Pharmaceuticals As Environmental Contaminants
The Claimed Intermediate Online Database | Drug Names to Search: Control F (PC) Command F (Mac) Open & Search in Ibooks App (Ipad)
Differences Between Mitiglinide/Voglibose Fixed- Dose
(12) United States Patent (10) Patent N0.: US 7,888,382 B2 Kiyono Et A]
Development and Validation of an LC-MS/MS Method for The
Stembook 2018.Pdf
Sitagliptin Versus Mitiglinide Switched from Mealtime Dosing of a Rapid-Acting Insulin Analog in Patients with Type 2 Diabetes: a Randomized, Parallel-Group Study
Beneficial Effect of Combination Therapy with Mitiglinide And
18Th Expert Committee on the Selection and Use of Essential Medicines
Risk of Hypoglycemia Associated with Repaglinide Combined With
Thiazolidinediones
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Differential Interactions of Nateglinide and Repaglinide on the Human -Cell Sulphonylurea Receptor 1
Drug Interactions of Sglt2 Inhibitors (Gliflozins) Involving Ugt Enzymes Dr
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Perturbation of Mitiglinide Metabolism by Chronic Unpredicted Mild Stress
Pregabalin Lercanidipine Hydrochloride Ulipristal Acetate
Research Article NOVEL DRUG DISCOVERY for DIABETES TYPE
The Proinsulin/Insulin
(12) Patent Application Publication (10) Pub. No.: US 2009/0311321 A1 Mimura Et Al
Tresiba, INN-Insulin Degludec
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Drug Composition for Prevention Or Inhibition of Advance of Diabetic Complication
WO 2U11/132171 Al
Efficacy and Safety of Mitiglinide in Diabetic Patients on Maintenance Hemodialysis
Nateglinide and Mitiglinide, but Not Sulfonylureas, Induce Insulin Secretion Through a Mechanism Mediated by Calcium
Pharmacology
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Standouts Melanoma Drug Yervoy, with Seemingly Better Tolerability
Oral Diabetes Medications
Drug Class Review on Oral Hypoglycemics
Online-Only Supplemental Material
S156.Full-Text.Pdf
Profile Uses and Administration Adverse Effects and Precautions
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
Mitiglinide, a Novel Oral Hypoglycemic Agent, Preserves the Cardioprotective Effect of Ischemic Preconditioning in Isolated Perfused Rat Hearts